title: [Use of prostaglandin F 2-alpha in placental period (author's transl)].
abstract: Reported in this paper is the intravenous application of prostaglandin F 2-alpha in the placental period and in cases of severe postpartum haemorrhage. -- Intravenous infusion of per-minute amounts between 40 and 80 micrograms in cases of atonic haemorrhage or between 30 and 45 micrograms in the placental period, in general, produced uterine contraction and clearly reduced blood loss.
mesh_terms: D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D009325:Nausea / Q000139:chemically induced; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D011460:Prostaglandins F / Q000009:adverse effects / Q000627:therapeutic use*; D013546:Sweating / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
chemical_list: D011460:Prostaglandins F
vernacular_title: Der Einsatz von Prostaglandin F2 alpha in der Nachgeburtsperiode.